Sunmax Biotechnology Co., Ltd. (TPEX: 4728)

Sunmax Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 9, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	14,868	11,110	7,407	4,499	4,384	4,368
Market Cap Growth	43.82%	50.00%	64.65%	2.61%	0.37%	69.20%
Enterprise Value	13,865	10,469	6,785	3,756	3,685	3,853
Last Close Price	273.00	196.71	125.89	73.80	70.19	68.44
PE Ratio	20.92	17.15	12.86	16.36	16.06	37.20
PS Ratio	8.45	6.58	5.29	4.34	5.12	7.35
PB Ratio	12.48	7.79	5.59	4.40	4.93	6.45
P/FCF Ratio	26.66	15.00	15.12	-461.83	17.05	15.84
P/OCF Ratio	27.94	13.09	11.49	18.49	11.33	15.09
EV/Sales Ratio	7.88	6.20	4.85	3.63	4.31	6.48
EV/EBITDA Ratio	13.50	11.18	8.47	9.45	10.66	21.07
EV/EBIT Ratio	14.77	11.70	8.83	10.22	11.09	22.01
EV/FCF Ratio	24.86	14.13	13.85	-385.54	14.33	13.97
Debt / Equity Ratio	0.13	0.12	0.05	0.10	0.15	0.17
Debt / EBITDA Ratio	0.16	0.17	0.08	0.23	0.35	0.62
Debt / FCF Ratio	0.29	0.23	0.13	-10.18	0.51	0.42
Asset Turnover	0.75	0.85	0.85	0.73	0.69	0.64
Inventory Turnover	2.78	3.39	3.23	3.53	4.65	2.37
Quick Ratio	1.22	2.12	2.52	2.06	3.12	2.78
Current Ratio	1.41	2.36	2.78	2.36	3.28	3.00
Return on Equity (ROE)	62.86%	45.48%	45.45%	25.69%	30.41%	15.16%
Return on Assets (ROA)	25.00%	28.30%	29.29%	16.12%	16.77%	11.70%
Return on Capital (ROIC)	45.16%	37.49%	38.23%	21.44%	22.92%	14.93%
Earnings Yield	4.78%	5.63%	7.21%	5.46%	5.43%	2.30%
FCF Yield	3.75%	6.67%	6.62%	-0.22%	5.86%	6.31%
Dividend Yield	3.96%	5.59%	7.55%	5.96%	2.85%	2.19%
Payout Ratio	72.69%	82.69%	44.89%	44.34%	34.31%	65.07%
Buyback Yield / Dilution	-0.01%	0.01%	-0.03%	0.02%	0.00%	-0.45%
Total Shareholder Return	3.95%	5.60%	7.52%	5.98%	2.85%	1.74%

Source: S&P Capital IQ. Standard template. Financial Sources.